A detailed insight of the tumor targeting using nanocarrier drug delivery system

References

• Adiseshaiah PP, Crist RM, Hook SS, McNeil SE. (2016). Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer. Nat Rev Clin Oncol 13:1–20.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Jurney P, Raythatha M, et al. (2015). Effect of shape, size, and aspect ratio on nanoparticle penetration and distribution inside solid tissues using 3D spheroid models. Adv Healthcare Mater 4:2269–80.
   Web of Science ®Google Scholar
• Aggarwal A, Ginsburg O, Fojo T. (2014). Cancer economics, policy and politics: what informs the debate? Perspectives from the EU, Canada and US. J Cancer Policy 2:1–11.
   Google Scholar
• Ahmad A, Khan F, Mishra RK, Khan R. (2019). Precision cancer nanotherapy: evolving role of multifunctional nanoparticles for cancer active targeting. J Med Chem 62:10475–96.
   PubMed Web of Science ®Google Scholar
• Allison RR, Bagnato VS, Sibata CH. (2010). Future of oncologic photodynamic therapy. Future Oncol 6:929–40.
   PubMed Web of Science ®Google Scholar
• Alphandery E, Grand-Dewyse P, Lefèvre R, et al. (2015). Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects. Expert Rev. Anticancer Ther 15:1233–55.
   PubMed Web of Science ®Google Scholar
• Amir KM, Khan Z, Ahmad I, et al. (2022). New [Pt (S2CNR2) Cl (PAr3)] complexes as anticancer agents. Inorg Chem Commun 136:109142.
   Web of Science ®Google Scholar
• Amoabediny G, Haghiralsadat F, Naderinezhad S, et al. (2018). Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: a comprehensive review. Int J Polym Mater 67:383–400.
   Web of Science ®Google Scholar
• Anarjan FS. (2019). Active targeting drug delivery nanocarriers: ligands. Nano-Struct Nano-Objects 19:100370.
   Google Scholar
• Anselmo AC, Mitragotri S. (2016). Nanoparticles in the clinic. Bioeng. Transl. Med 1:10–29.
   PubMed Web of Science ®Google Scholar
• Anselmo AC, Mitragotri S. (2019). Nanoparticles in the clinic: an update. Bioeng Transl Med 4:e10143.
   PubMed Web of Science ®Google Scholar
• Anselmo AC, Mitragotri S. (2019). Nanoparticles in the clinic: an update. Bioeng Trans Med 4:10143–59.
   PubMed Web of Science ®Google Scholar
• Aravind A, Varghese SH, Veeranarayanan S, et al. (2012). Aptamer-labeled PLGA nanoparticles for targeting cancer cells. Cancer Nano 3:1–12.
   PubMedGoogle Scholar
• Bartczak D, Muskens OL, Nitti S, et al. (2012). Interactions of human endothelial cells with gold nanoparticles of different morphologies. Small 8:122–30.
   PubMed Web of Science ®Google Scholar
• Barua S, Yoo J-W, Kolhar P, et al. (2013). Particle shape enhances specificity of antibody-displaying nanoparticles. Proc Natl Acad Sci U S A 110:3270–5.
   PubMed Web of Science ®Google Scholar
• Beljanski V, Hiscott J. (2012). The use of oncolytic viruses to overcome lung cancer drug resistance. Curr Opin Virol 2:629–35.
   PubMed Web of Science ®Google Scholar
• Bhakta GD, Saeed ME, Greten HJ, Efferth T. (2015). Dis-organizing centrosomal clusters: specific cancer therapy for a generic spread? Curr Med Chem 22:685–94.
   PubMed Web of Science ®Google Scholar
• Bilynsky C, Millot N, Papa AL. (2022). Radiation nanosensitizers in cancer therapy—from preclinical discoveries to the outcomes of early clinical trials. Bioeng Trans Med 7:e10256.
   PubMed Web of Science ®Google Scholar
• Boisselier E, Astruc D. (2009). Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 38:1759.
   PubMed Web of Science ®Google Scholar
• Bosetti C, Rosato V, Li D, et al. (2014). Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the international pancreatic cancer case-control consortium. Ann Oncol 25:2065–72.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 68:394–424.
   PubMed Web of Science ®Google Scholar
• Bruckman MA, Randolph LN, VanMeter A, et al. (2014). Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and-spheres in mice. Virology 449:163–73.
   PubMed Web of Science ®Google Scholar
• Champion JA, Mitragotri S. (2009). Shape induced inhibition of phagocytosis of polymer particles. Pharm Res 26:244–9.
   PubMed Web of Science ®Google Scholar
• Chan MH, Lin HM. (2015). Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking. Biomaterials 46:149–58.
   PubMed Web of Science ®Google Scholar
• Chaudhry M, Lyon P, Coussios C, Carlisle R. (2022). Thermosensitive liposomes: a promising step toward localised chemotherapy. Expert Opin Drug Deliv 19:899–912.
   PubMed Web of Science ®Google Scholar
• Chen CH, Wu YJ, Chen JJ. (2015a). Gold nanotheranostics: photothermal therapy and imaging of Mucin 7 conjugated antibody nanoparticles for urothelial cancer. Biomed Res Int 2015:813632.
   PubMed Web of Science ®Google Scholar
• Chen Q, Wang X, Wang C, et al. (2015b). Drug-induced self-assembly of modified albumins as nano-theranostics for tumor-targeted combination therapy. ACS Nano 9:5223–33.
   PubMed Web of Science ®Google Scholar
• Chilakamarthi U, Giribabu L. (2017). Photodynamic therapy: past, present and future. Chem Rec 17:775–802.
   PubMed Web of Science ®Google Scholar
• Chowdhury M, Schumann C, Bhakta-Guha D, Guha G. (2016). Cancer nanotheranostics: strategies, promises and impediments. Biomed Pharmacother 84:291–304.
   PubMed Web of Science ®Google Scholar
• Christian DA, Cai S, Garbuzenko OB, et al. (2009). Flexible filaments for in vivo imaging and delivery: persistent circulation of filomicelles opens the dosage window for sustained tumor shrinkage. Mol Pharmaceutics 6:1343–52.
   PubMed Web of Science ®Google Scholar
• Chuah LH, Billa N, Roberts CJ, et al. (2013). Curcumin-containing chitosan nanoparticles as a potential mucoadhesive delivery system to the colon. Pharm Dev Technol 18:591–9.
   PubMed Web of Science ®Google Scholar
• Cisterna BA, Kamaly N, Choi WI, et al. (2016). Targeted nanoparticles for colorectal cancer. Nanomedicine 11:2443–56.
   PubMed Web of Science ®Google Scholar
• Conroy T, Hammel P, Hebbar M, et al. (2018). FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med 379:2395–406.
   PubMed Web of Science ®Google Scholar
• Danhier F, Feron O, Préat V. (2010). To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148:135–46.
   PubMed Web of Science ®Google Scholar
• Deryugina EI, Quigley JP. (2010). Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions. Biochim Biophys Acta Mol Cell Res 1803:103–20.
   PubMed Web of Science ®Google Scholar
• Deshpande PP, Biswas S, Torchilin VP. (2013). Current trends in the use of liposomes for tumor targeting. Nanomedicine (Lond) 8:1509–28.
   PubMed Web of Science ®Google Scholar
• Din F, Choi JY, Kim DW, et al. (2017a). Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration. Drug Deliv 24:502–10.
   PubMed Web of Science ®Google Scholar
• Din F, Kim DW, Choi JY et al. (2017b). Irinotecan-loaded double-reversible thermogel with improved antitumor efficacy without initial burst effect and toxicity for intramuscular administration. Acta Biomater 54:239–48.
   Google Scholar
• Dinndorf PA, Gootenberg J, Cohen MH, et al. (2007). FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL). Oncologist 12:991–8.
   PubMed Web of Science ®Google Scholar
• Dixit S, Miller K, Zhu Y, et al. (2015). Dual receptor-targeted theranostic nanoparticles for localized delivery and activation of photodynamic therapy drug in glioblastomas. Mol Pharm 12:3250–60.
   PubMedGoogle Scholar
• Doughty A, Hoover A, Layton E, et al. (2019). Nanomaterial applications in photothermal therapy for cancer. Materials 12:779.
   PubMed Web of Science ®Google Scholar
• Douglas T, Young M. (2006). Viruses: making friends with old foes. Science 312:873–5.
   PubMed Web of Science ®Google Scholar
• Draz MS, Fang BA, Zhang P, et al. (2014). Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections. Theranostics 4:872–92.
   PubMed Web of Science ®Google Scholar
• Ediriwickrema A, Saltzman WM. (2015). Nanotherapy for cancer: targeting and multifunctionality in the future of cancer therapies. ACS Biomater Sci Eng 1:64–78.
   PubMed Web of Science ®Google Scholar
• Egusquiaguirre SP, Igartua M, Hernández RM, Pedraz JL. (2012). Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research. Clin Transl Oncol 14:83–93.
   PubMed Web of Science ®Google Scholar
• Farshbaf M, Valizadeh H, Panahi Y, et al. (2022). The impact of protein corona on the biological behavior of targeting nanomedicines. Int J Pharm 614:121458.
   PubMedGoogle Scholar
• Fulbright LE, Ellermann M, Arthur JC. (2017). The microbiome and the hallmarks of cancer. PLoS Pathog 13:e1006480.
   PubMed Web of Science ®Google Scholar
• Gabizon A, Martin F. (1997). Polyethylene glycol-coated (pegylated) liposomal doxorubicin: rationale for use in solid tumours. Drugs 54:15–21.
   PubMed Web of Science ®Google Scholar
• Gan CW, Feng S-S. 2014. Transferrin-conjugated nanoparticles of poly (lactide)-D-α-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood–brain barrier. Chem Eng J 31:826–49.
   Google Scholar
• Gao G, Sun X, Liang G. (2021). Nanoagent-promoted mild-temperature photothermal therapy for cancer treatment. Adv Funct Mater 31:2100738.
   Web of Science ®Google Scholar
• Gao X, Cui Y, Levenson RM, et al. (2004). In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22:969–76.
   PubMed Web of Science ®Google Scholar
• Geng Y, Dalhaimer P, Cai S, et al. (2007). Shape effects of filaments versus spherical particles in flow and drug delivery. Nature Nanotech 2:249–55.
   PubMed Web of Science ®Google Scholar
• Gillen S, Schuster T, Meyer zum Büschenfelde C, et al. (2010). Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med 7:e1000267.
   PubMed Web of Science ®Google Scholar
• Goddard ZR, Marín MJ, Russell DA, Searcey M. (2020). Active targeting of gold nanoparticles as cancer therapeutics. Chem Soc Rev 49:8774–89.
   PubMed Web of Science ®Google Scholar
• Greish K. (2007). Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target 15:457–64.
   PubMed Web of Science ®Google Scholar
• Grodzinski P, Kircher M, Goldberg M, Gabizon A. 2019. Integrating nanotechnology into cancer care. ACS Nano 13(7):7370–76.
   Google Scholar
• Guo J, Schlich M, Cryan JF, O’Driscoll CM. (2017). Targeted drug delivery via folate receptors for the treatment of brain cancer: can the promise deliver? J Pharm Sci 106:3413–20.
   PubMed Web of Science ®Google Scholar
• Haider N, Fatima S, Taha M, et al. (2020). Nanomedicines in diagnosis and treatment of cancer: an update. Curr Pharm Des 26:1216–31.
   PubMed Web of Science ®Google Scholar
• He H, Liu L, Morin EE, et al. (2019). Survey of clinical translation of cancer nanomedicines—lessons learned from successes and failures. Acc Chem Res 52:2445–61.
   PubMed Web of Science ®Google Scholar
• He Q, Ma M, Wei C, Shi J. (2012). Mesoporous carbon@silicon-silica nanotheranostics for synchronous delivery of insoluble drugs and luminescence imaging. Biomaterials 33:4392–402.
   PubMed Web of Science ®Google Scholar
• He Z, Zhang Y, Feng N. (2020). Cell membrane-coated nanosized active targeted drug delivery systems homing to tumor cells: a review. Mater Sci Eng C 106:110298.
   PubMed Web of Science ®Google Scholar
• Hirsjarvi S, Passirani C, Benoit J-P. (2011). Passive and active tumour targeting with nanocarriers. CDDT 8:188–96.
   Google Scholar
• Howell M, Valle JW. (2015). The role of adjuvant chemotherapy and radiotherapy for cholangiocarcinoma. Best Pract Res Clin Gastroenterol 29:333–43.
   PubMed Web of Science ®Google Scholar
• Hruban R. 2010. Ductal adenocarcinoma of the pancreas. WHO Classification of Digestive Tumors, 281–90.
   Google Scholar
• Hruban RH, Canto MI, Goggins M, et al. (2010). Update on familial pancreatic cancer. Adv Surg 44:293–311.
   PubMedGoogle Scholar
• Hu C, He X, Chen Y, et al. (2021). Metformin mediated PD-L1 downregulation in combination with photodynamic-immunotherapy for treatment of breast cancer. Adv Funct Mater 31:2007149.
   Web of Science ®Google Scholar
• Hu C, Lei T, Wang Y, et al. (2020). Phagocyte-membrane-coated and laser-responsive nanoparticles control primary and metastatic cancer by inducing anti-tumor immunity. Biomaterials 255:120159.
   PubMed Web of Science ®Google Scholar
• Hunt NJ, McCourt PA, Kuncic Z, et al. (2022). Opportunities and challenges for nanotherapeutics for the aging population. Front Nanotechnol 4:1.
   Google Scholar
• Imran M, Das KR, Naik MM. (2019). Co-selection of multi-antibiotic resistance in bacterial pathogens in metal and microplastic contaminated environments: an emerging health threat. Chemosphere 215:846–57.
   PubMed Web of Science ®Google Scholar
• Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. (2008). Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg 393:535–45.
   PubMed Web of Science ®Google Scholar
• Ishtiaq S, Shah KU, Ur-Rehman T, Ud-Din F. 2020. Gold nanorods: new generation drug delivery platform. Metal nanoparticles for drug delivery and diagnostic applications, 59–84.
   Google Scholar
• Jamshaid H, Ud Din F. 2021. Emerging lipid-based nanomaterials for cancer theranostics. Cancer nanotheranostics. Berlin: Springer, 125–59.
   Google Scholar
• Jazieh AR, Da’ar OB, Alkaiyat M, et al. (2019). Cancer incidence trends from 1999 to 2015 and contributions of various cancer types to the overall burden: projections to 2030 and extrapolation of economic burden in saudi arabia. CMAR 11:9665–74.
   Google Scholar
• Jia W, Liu R, Wang Y, et al. (2022). Dual-responsive nanoparticles with transformable shape and reversible charge for amplified chemo-photodynamic therapy of breast cancer. Acta Pharm Sin B 12:3354–66.
   PubMed Web of Science ®Google Scholar
• Jin CS, Cui L, Wang F, et al. (2014). Targeting-triggered porphysome nanostructure disruption for activatable photodynamic therapy. Adv Healthc Mater 3:1240–9.
   PubMed Web of Science ®Google Scholar
• Kamaly N, Fredman G, Fojas JJR, et al. (2016). Targeted interleukin-10 nanotherapeutics developed with a microfluidic chip enhance resolution of inflammation in advanced atherosclerosis. ACS Nano 10:5280–92.
   PubMed Web of Science ®Google Scholar
• Kessentini S, Barchiesi D. (2012). Quantitative comparison of optimized nanorods, nanoshells and hollow nanospheres for photothermal therapy. Biomed Opt Express 3:590–604.
   PubMed Web of Science ®Google Scholar
• Khan MW, Zou C, Hassan S, et al. (2022). Cisplatin and oleanolic acid Co-loaded pH-sensitive CaCO3 nanoparticles for synergistic chemotherapy. RSC Adv 12:14808–18.
   PubMed Web of Science ®Google Scholar
• Kirtane AR, Kalscheuer SM, Panyam J. (2013). Exploiting nanotechnology to overcome tumor drug resistance: challenges and opportunities. Adv Drug Deliv Rev 65:1731–47.
   PubMed Web of Science ®Google Scholar
• Kluza E, Jacobs I, Hectors SJ, et al. (2012). Dual-targeting of αvβ3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo. J Control Release 158:207–14.
   PubMed Web of Science ®Google Scholar
• Lammers T, Kiessling F, Hennink WE, Storm G. (2010). Nanotheranostics and image-guided drug delivery: current concepts and future directions. Mol Pharmaceutics 7:1899–912.
   PubMed Web of Science ®Google Scholar
• Lawrance IC, Sherrington C, Murray K. (2006). Poor correlation between clinical impression, the small colonic polyp and their neoplastic risk. J Gastroenterol Hepatol 21:563–8.
   PubMed Web of Science ®Google Scholar
• Lee SY, Kang MS, Jeong WY, et al. (2020). Hyaluronic acid-based theranostic nanomedicines for targeted cancer therapy. Cancers 12:940.
   PubMed Web of Science ®Google Scholar
• Li R, Wu R, Zhao L, et al. (2011). Folate and iron difunctionalized multiwall carbon nanotubes as dual-targeted drug nanocarrier to cancer cells. Carbon 49:1797–805.
   Web of Science ®Google Scholar
• Li Y-J, Wu J-Y, Wang J-M, Xiang D-X. (2020). Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer. J Control Release 320:105–11.
   PubMed Web of Science ®Google Scholar
• Lin C, Tong F, Liu R, et al. (2020). GSH-responsive SN38 dimer-loaded shape-transformable nanoparticles with iRGD for enhancing chemo-photodynamic therapy. Acta Pharm Sin B 10:2348–61.
   PubMed Web of Science ®Google Scholar
• Lin WJ, Lee W-C, Shieh M-J. (2017). Hyaluronic acid conjugated micelles possessing CD44 targeting potential for gene delivery. Carbohydr Polym 155:101–8.
   PubMed Web of Science ®Google Scholar
• Liu D, Auguste DT. (2015). Cancer targeted therapeutics: from molecules to drug delivery vehicles. J Control Release 219:632–43.
   PubMed Web of Science ®Google Scholar
• Liu GX, Fang GQ, Xu W. (2014). Dual targeting biomimetic liposomes for paclitaxel/DNA combination cancer treatment. IJMS 15:15287–303.
   Google Scholar
• Liu R, An Y, Jia W, et al. (2020). Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer. J Control Release 321:589–601.
   PubMed Web of Science ®Google Scholar
• Liu R, Hu C, Yang Y, et al. (2019). Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment. Acta Pharm Sin B 9:410–20.
   PubMed Web of Science ®Google Scholar
• Liu TW, MacDonald TD, Jin CS, et al. (2013). Inherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastases. ACS Nano 7:4221–32.
   PubMed Web of Science ®Google Scholar
• Liu X, Madhankumar A, Slagle-Webb B, et al. (2011). Heavy chain ferritin siRNA delivered by cationic liposomes increases sensitivity of cancer cells to chemotherapeutic agents. Cancer Res 71:2240–9.
   PubMed Web of Science ®Google Scholar
• Liu Z, Cai W, He L, et al. (2007). In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nature Nanotech 2:47–52.
   PubMed Web of Science ®Google Scholar
• Lu W, Zhang G, Zhang R, et al. (2010). Tumor site–specific silencing of NF-κB p65 by targeted hollow gold nanosphere–mediated photothermal transfectionsilencing of NF-κB p65 by photothermal transfection. Cancer Res 70:3177–88.
   PubMed Web of Science ®Google Scholar
• Lu YJ, Lin PY, Huang PH, et al. (2018). Magnetic graphene oxide for dual targeted delivery of doxorubicin and photothermal therapy. Nanomaterials (Basel) 8:193.
   PubMedGoogle Scholar
• Ma Y, Nolte RJ, Cornelissen JJ. (2012). Virus-based nanocarriers for drug delivery. Adv Drug Deliv Rev 64:811–25.
   PubMed Web of Science ®Google Scholar
• Madamsetty VS, Mukherjee A, Mukherjee S. (2019). Recent trends of the bio-inspired nanoparticles in cancer theranostics. Front Pharmacol 10:1264.
   PubMed Web of Science ®Google Scholar
• Maji R, Dey NS, Satapathy BS, et al. (2014). Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy. Int J Nanomed 9:3107.
   PubMed Web of Science ®Google Scholar
• Mamnoon B, Loganathan J, Confeld MI, et al. (2021). Targeted polymeric nanoparticles for drug delivery to hypoxic, triple-negative breast tumors. ACS Appl Bio Mater 4:1450–60.
   PubMedGoogle Scholar
• Manandhar S, Sjöholm E, Bobacka J, et al. (2021). Polymer-drug conjugates as nanotheranostic agents. JNT 2:63–81.
   Google Scholar
• Martinelli C, Pucci C, Ciofani G. (2019). Nanostructured carriers as innovative tools for cancer diagnosis and therapy. APL Bioeng 3:011502.
   PubMed Web of Science ®Google Scholar
• Mattheolabakis G, Ling D, Ahmad G, Amiji M. (2016). Enhanced anti-tumor efficacy of lipid-modified platinum derivatives in combination with survivin silencing siRNA in resistant non-small cell lung cancer. Pharm Res 33:2943–53.
   PubMed Web of Science ®Google Scholar
• Montaseri H, Kruger CA, Abrahamse H. (2020). Organic nanoparticle based active targeting for photodynamic therapy treatment of breast cancer cells. Oncotarget 11:2120–36.
   PubMedGoogle Scholar
• Moses C, Garcia-Bloj B, Harvey AR, Blancafort P. (2018). Hallmarks of cancer: the CRISPR generation. Eur J Cancer 93:10–8.
   PubMed Web of Science ®Google Scholar
• Muhammad F, Guo M, Wang A, et al. (2014). Responsive delivery of drug cocktail via mesoporous silica nanolamps. J Colloid Interface Sci 434:1–8.
   PubMed Web of Science ®Google Scholar
• Muhanna N, Jin CS, Huynh E, et al. (2015). Phototheranostic porphyrin nanoparticles enable visualization and targeted treatment of head and neck cancer in clinically relevant models [Research Paper]. Theranostics 5:1428–43.
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Paul M, Mukherjee S. (2019). Recent progress in the theranostics application of nanomedicine in lung cancer. Cancers 11:597.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Chowdhury D, Kotcherlakota R, et al. (2014). Potential theranostics application of bio-synthesized silver nanoparticles (4-in-1 system). Theranostics 4:316–35.
   PubMed Web of Science ®Google Scholar
• Mundekkad D, Cho WC. (2022). Nanoparticles in clinical translation for cancer therapy. IJMS 23:1685.
   Google Scholar
• Muthoosamy K, Abubakar IB, Bai RG, et al. (2016). Exceedingly higher co-loading of curcumin and paclitaxel onto polymer-functionalized reduced graphene oxide for highly potent synergistic anticancer treatment. Sci Rep 6:1–14.
   PubMed Web of Science ®Google Scholar
• Ng KK, Lovell JF, Zheng G. (2011). Lipoprotein-inspired nanoparticles for cancer theranostics. Acc Chem Res 44:1105–13.
   PubMed Web of Science ®Google Scholar
• Nicolas J, Mura S, Brambilla D, et al. (2013). Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem Soc Rev 42:1147–235.
   PubMed Web of Science ®Google Scholar
• Nowotnik DP, Cvitkovic E. (2009). ProLindac™(AP5346): a review of the development of an HPMA DACH platinum polymer therapeutic. Adv Drug Deliv Rev 61:1214–9.
   PubMed Web of Science ®Google Scholar
• Obraztsov AN, Obraztsova EA, Tyurnina AV, Zolotukhin AA. (2007). Chemical vapor deposition of thin graphite films of nanometer thickness. Carbon 45:2017–21.
   Web of Science ®Google Scholar
• Ogawa K, Kobuke Y. (2008). Recent advances in two-photon photodynamic therapy. ACAMC 8:269–79.
   Google Scholar
• Oishi M, Nakaogami J, Ishii T, Nagasaki Y. (2006). Smart PEGylated gold nanoparticles for the cytoplasmic delivery of siRNA to induce enhanced gene silencing. Chem Lett 35:1046–7.
   Web of Science ®Google Scholar
• Orang AV, Petersen J, McKinnon RA, Michael MZ. (2019). Micromanaging aerobic respiration and glycolysis in cancer cells. Mol Metab 23:98–126.
   PubMed Web of Science ®Google Scholar
• Pang Z, Gao H, Yu Y, et al. (2011). Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin. Bioconjugate Chem 22:1171–80.
   PubMed Web of Science ®Google Scholar
• Patra HK, U, Khaliq N, Romu T, et al. (2014). MRI-visual order-disorder micellar nanostructures for smart cancer theranostics. Adv Healthcare Mater 3:526–35.
   Web of Science ®Google Scholar
• Pattenden LK, Middelberg AP, Niebert M, Lipin DI. (2005). Towards the preparative and large-scale precision manufacture of virus-like particles. Trends Biotechnol 23:523–9.
   PubMed Web of Science ®Google Scholar
• Peiris PM, Toy R, Doolittle E, et al. (2012). Imaging metastasis using an integrin-targeting chain-shaped nanoparticle. ACS Nano 6:8783–95.
   PubMed Web of Science ®Google Scholar
• Peng G, Tisch U, Adams O, et al. (2009). Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nature Nanotech 4:669–73.
   PubMed Web of Science ®Google Scholar
• Perey L, Hayes DF, Maimonis P, et al. (1992). Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen. Cancer Res 52:2563–8.
   PubMed Web of Science ®Google Scholar
• Pérez-Herrero E, Fernández-Medarde A. (2015). Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm 93:52–79.
   PubMed Web of Science ®Google Scholar
• Prokopiou E, Ryder S, Walsh J. (2013). Tumour vasculature targeting agents in hybrid/conjugate drugs. Angiogenesis 16:503–24.
   PubMed Web of Science ®Google Scholar
• Qiao Y, Wan J, Zhou L, et al. (2019). Stimuli-responsive nanotherapeutics for precision drug delivery and cancer therapy. Wiley Interdiscip Rev Nanomed 11:e1527.
   PubMed Web of Science ®Google Scholar
• Raimondi S, Lowenfels AB, Morselli-Labate AM, et al. (2010). Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 24:349–58.
   PubMed Web of Science ®Google Scholar
• Raja HN, Imran B, Din FU. 2022. Trigger-sensitive nanoparticle for drug delivery. Drug delivery using nanomaterials. Boca Raton, FL: CRC Press, 155–80.
   Google Scholar
• Rajora MA, Ding L, Valic M, et al. (2017). Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma. Chem Sci 8:5371–84.
   PubMed Web of Science ®Google Scholar
• Rastinehad AR, Anastos H, Wajswol E, et al. (2019). Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study. Proc Natl Acad Sci U S A 116:18590–6.
   PubMed Web of Science ®Google Scholar
• Ren J, Shen S, Wang D, et al. (2012). The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2. Biomaterials 33:3324–33.
   PubMed Web of Science ®Google Scholar
• Roa WH, Azarmi S, Al-Hallak MK, et al. (2011). Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model. J Control Release 150:49–55.
   PubMed Web of Science ®Google Scholar
• Robertson KL, Soto CM, Archer MJ, et al. (2011). Engineered T4 viral nanoparticles for cellular imaging and flow cytometry. Bioconjugate Chem 22:595–604.
   PubMed Web of Science ®Google Scholar
• Ruan S, Hu C, Tang X, et al. (2016). Increased gold nanoparticle retention in brain tumors by in situ enzyme-induced aggregation. ACS Nano 10:10086–98.
   PubMed Web of Science ®Google Scholar
• Ruan S, Rou X, Lin Q, et al. (2019). Aggregable nanoparticles-enabled chemotherapy and autophagy inhibition combined with anti-PD-L1 antibody for improved glioma treatment. Nano Lett 19:8318–32.
   PubMed Web of Science ®Google Scholar
• Sabir F, Asad MI, Qindeel M, et al. (2019). Polymeric nanogels as versatile nanoplatforms for biomedical applications. J Nanomater 2019:1–16.
   Web of Science ®Google Scholar
• Sahoo AK, Banerjee S, Ghosh SS, Chattopadhyay A. (2014). Simultaneous RGB emitting Au nanoclusters in chitosan nanoparticles for anticancer gene theranostics. ACS Appl Mater Interfaces 6:712–24.
   PubMed Web of Science ®Google Scholar
• Sahu NK, Singh NS, Pradhan L, Bahadur D. (2014). Ce3+ sensitized GdPO4:Tb3+ with iron oxide nanoparticles: a potential biphasic system for cancer theranostics. Dalton Trans 43:11728–38.
   PubMed Web of Science ®Google Scholar
• Schmitt NC, Page BR. (2018). Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients. Int J Audiol 57:S48–S53.
   Web of Science ®Google Scholar
• Shahin M, Ahmed S, Kaur K, Lavasanifar A. (2011). Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel. Biomaterials 32:5123–33.
   PubMed Web of Science ®Google Scholar
• Shahin M, Lavasanifar A. (2010). Novel self-associating poly (ethylene oxide)-b-poly (ɛ-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery. Int J Pharm 389:213–22.
   PubMed Web of Science ®Google Scholar
• Shahin M, Soudy R, Aliabadi HM, et al. (2013). Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity. Biomaterials 34:4089–97.
   PubMed Web of Science ®Google Scholar
• Shahzad K, Mushtaq S, Rizwan M, et al. (2021). Field-controlled magnetoelectric core-shell CoFe2O4@ BaTiO3 nanoparticles as effective drug carriers and drug release in vitro. Mater Sci Eng C 119:111444.
   PubMed Web of Science ®Google Scholar
• Shi H, Ye X, He X, et al. (2014). Au@Ag/Au nanoparticles assembled with activatable aptamer probes as smart “nano-doctors” for image-guided cancer thermotherapy. Nanoscale 6:8754.
   PubMed Web of Science ®Google Scholar
• Shi X, Gong H, Li Y, et al. (2013). Graphene-based magnetic plasmonic nanocomposite for dual bioimaging and photothermal therapy. Biomaterials 34:4786–93.
   PubMed Web of Science ®Google Scholar
• Sibgha B, Maryam B, AM, Yousaf, et al. 2021. Emerging nanomaterials for cancer therapy. In: Nanotherapeutic strategies and new pharmaceuticals (Part 1). Singapore: Bentham Science, 104–39.
   Google Scholar
• Siegel RL, Miller KD, Jemal A. (2019). Cancer statistics. CA: Cancer J Clin 69:7–34.
   PubMed Web of Science ®Google Scholar
• Singh A, Sahoo SK. (2014). Magnetic nanoparticles: a novel platform for cancer theranostics. Drug Discov Today 19:474–81.
   PubMed Web of Science ®Google Scholar
• Singh P, Prasuhn D, Yeh RM, et al. (2007). Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo. J Control Release 120:41–50.
   PubMed Web of Science ®Google Scholar
• Sohail S, Fakhar DU. 2021. Nanotheranostics: the future remedy of neurological disorders. Cancer nanotheranostics. Switzerland: Springer, 117–54.
   Google Scholar
• Song Z, Lin Y, Zhang X, et al. (2017). Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects. IJN 12:1941–58.
   Google Scholar
• Sun Z, Yan X, Liu Y, et al. (2017). Application of dual targeting drug delivery system for the improvement of anti-glioma efficacy of doxorubicin. Oncotarget 8:58823–34.
   PubMedGoogle Scholar
• Tak YK, Pal S, Naoghare PK, et al. (2015). Shape-dependent skin penetration of silver nanoparticles: does it really matter? Sci Rep 5:1–11.
   Web of Science ®Google Scholar
• Tang W-L, Tang W-H, Li S-D. (2018). Cancer theranostic applications of lipid-based nanoparticles. Drug Discov 23:1159–66.
   Google Scholar
• Tewari D, Rawat P, Singh PK. (2019). Adverse drug reactions of anticancer drugs derived from natural sources. Food Chem Toxicol 123:522–35.
   PubMed Web of Science ®Google Scholar
• Thakor AS, Gambhir SS. (2013). Nanooncology: the future of cancer diagnosis and therapy. CA A Cancer J Clin 63:395–418.
   PubMed Web of Science ®Google Scholar
• Tolcher AW, Mayer LD. (2018). Improving combination cancer therapy: the CombiPlex® development platform. Future Oncol 14:1317–32.
   PubMed Web of Science ®Google Scholar
• Torchilin V. (2011). Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 63:131–5.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. (2015). Global cancer statistics, 2012. CA Cancer J Clin 65:87–108.
   PubMed Web of Science ®Google Scholar
• Toy R, Peiris PM, Ghaghada KB, Karathanasis E. (2014). Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine 9:121–34.
   PubMed Web of Science ®Google Scholar
• Truffi M, Fiandra L, Sorrentino L, et al. (2016). Ferritin nanocages: a biological platform for drug delivery, imaging and theranostics in cancer. Pharmacol Res 107:57–65.
   PubMed Web of Science ®Google Scholar
• ud Din F, Aman W, Ullah I, et al. (2017). Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. IJN 12:7291–309.
   Google Scholar
• Verschraegen CF, Gilbert BE, Loyer E, et al. (2004). Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20 (s)-camptothecin in patients with advanced pulmonary malignancies. Clin Cancer Investig J 10:2319–26.
   Google Scholar
• Wan G, Chen B, Li L, et al. (2018). Nanoscaled red blood cells facilitate breast cancer treatment by combining photothermal/photodynamic therapy and chemotherapy. Biomaterials 155:25–40.
   PubMed Web of Science ®Google Scholar
• Wang CF, Sarparanta MP, Mäkilä EM, et al. (2015). Multifunctional porous silicon nanoparticles for cancer theranostics. Biomaterials 48:108–18.
   PubMed Web of Science ®Google Scholar
• Wang H, Ding T, Guan J, et al. (2020). Interrogation of folic acid-functionalized nanomedicines: the regulatory roles of plasma proteins reexamined. ACS Nano 14:14779–89.
   PubMed Web of Science ®Google Scholar
• Wang LS, Chuang MC, Ho JA. (2012). Nanotheranostics–a review of recent publications. Int J Nanomed 7:4679–95.
   PubMed Web of Science ®Google Scholar
• Wang Z, Huang P, Jacobson O, et al. (2016). Biomineralization-inspired synthesis of copper sulfide-ferritin nanocages as cancer theranostics. ACS Nano 10:3453–60.
   PubMed Web of Science ®Google Scholar
• Wang Z, Qiao R, Tang N, et al. (2017). Active targeting theranostic iron oxide nanoparticles for MRI and magnetic resonance-guided focused ultrasound ablation of lung cancer. Biomaterials 127:25–35.
   PubMed Web of Science ®Google Scholar
• Weissig V, Pettinger TK, Murdock N. (2014). Nanopharmaceuticals (part 1): products on the market. Int J Nanomed 9:4357–73.
   PubMed Web of Science ®Google Scholar
• Werner ME, Cummings ND, Sethi M, et al. (2013). Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 86:463–8.
   PubMed Web of Science ®Google Scholar
• Wu F, Su H, Cai Y, et al. (2018). Porphyrin-implanted carbon nanodots for photoacoustic imaging and in vivo breast cancer ablation. ACS Appl Bio Mater 1:110–7.
   Google Scholar
• Wu W, Zheng Y, Wang R, et al. (2012). Antitumor activity of folate-targeted, paclitaxelloaded polymeric micelles on a human esophageal EC9706 cancer cell line. Int J Nanomed 7:3487.
   PubMed Web of Science ®Google Scholar
• Xiao W, Gao H. (2018). The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system. Int J Pharm 552:328–39.
   PubMed Web of Science ®Google Scholar
• Xiao W, Wang Y, Zhang H, et al. (2021). The protein corona hampers the transcytosis of transferrin-modified nanoparticles through blood–brain barrier and attenuates their targeting ability to brain tumor. Biomaterials 274:120888.
   PubMed Web of Science ®Google Scholar
• Xie J, Liu G, Eden HS, et al. (2011). Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. Acc Chem Res 44:883–92.
   PubMed Web of Science ®Google Scholar
• Xie R, Ruan Shaobo Liu J, Qin L, et al. (2021). Furin-instructed aggregated gold nanoparticles for re-educating tumor associated macrophages and overcoming breast cancer chemoresistance. Biomaterials 275:120891.
   PubMed Web of Science ®Google Scholar
• Xing R, Mustapha O, Ali T, et al. 2021. Development, characterization, and evaluation of SLN-loaded thermoresponsive hydrogel system of topotecan as biological macromolecule for colorectal delivery. Biomed Res Int 2021:9968602.
   Google Scholar
• Xiong XB, Uludağ H, Lavasanifar A. (2010). Virus-mimetic polymeric micelles for targeted siRNA delivery. Biomaterials 31:5886–93.
   PubMed Web of Science ®Google Scholar
• Xu Q, Liu Y, Su S, et al. (2012). Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles. Biomaterials 33:1627–39.
   PubMed Web of Science ®Google Scholar
• Xu W, Xu M, Xiao Y, et al. (2022). Changes in target ability of nanoparticles due to protein corona composition and disease state. Asian J Pharm 17:401–11.
   PubMedGoogle Scholar
• Yang L, Tseng YT, Suo G, et al. (2015). Photothermal therapeutic response of cancer cells to aptamer-gold nanoparticle-hybridized graphene oxide under NIR illumination. ACS Appl Mater Inter 7:5097–106.
   PubMed Web of Science ®Google Scholar
• Yang T, Wang Y, Ke H, et al. (2016). Protein-nanoreactor-assisted synthesis of semiconductor nanocrystals for efficient cancer theranostics. Adv Mater 28:5923–30.
   PubMed Web of Science ®Google Scholar
• Yousaf A, Shahzad Y, ud Din F, et al. 2021. Polymeric nanofibers for wound dressing applications. In: Nanotherapeutic strategies and new pharmaceuticals (Part 2). Singapore: Bentham Science Publishers BV, 113–41.
   Google Scholar
• Yu G, Ali Z, S, Khan A, et al. (2021). Preparation, pharmacokinetics, and antitumor potential of miltefosine-loaded nanostructured lipid carriers. IJN 16:3255–73.
   Google Scholar
• Yu KM, Kim D, Lee IH, et al. (2011). Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles. Small 7:2241–9.
   PubMed Web of Science ®Google Scholar
• Yu M, K, Park J, Jon S. (2012). Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2:3–44.
   PubMed Web of Science ®Google Scholar
• Yuan M, Qiu Y, Zhang L, et al. (2016). Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma. Drug Deliv 23:1171–83.
   PubMed Web of Science ®Google Scholar
• Zeb A, Rana I, Choi HI, et al. (2020). Potential and applications of nanocarriers for efficient delivery of biopharmaceuticals. Pharmaceutics 12:1184.
   PubMed Web of Science ®Google Scholar
• Zein R, Sharrouf W, Selting K. (2020). Physical properties of nanoparticles that result in improved cancer targeting. J Oncol 13:5194780.
   PubMed Web of Science ®Google Scholar
• Zhang X, Xi Z, Machuki JOa, et al. (2019). Gold cube-in-cube based oxygen nanogenerator: a theranostic nanoplatform for modulating tumor microenvironment for precise chemo-phototherapy and multimodal imaging. ACS Nano 13:5306–25.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li M, Gao X, et al. (2019). Nanotechnology in cancer diagnosis: progress, challenges and opportunities. J Hematol Oncol Pharm 12:1–13.
   Google Scholar
• Zhou Q, Zhang L, Yang T, Wu H. (2018). Stimuli-responsive polymeric micelles for drug delivery and cancer therapy. IJN 13:2921–42.
   Google Scholar
• Zhou Y, Tong F, Gu W, et al. (2022). Co-delivery of photosensitizer and diclofenac through sequentially responsive bilirubin nanocarriers for combating hypoxic tumors. Acta Pharm Sin B 12:1416–31.
   PubMed Web of Science ®Google Scholar